Issue 39, 2019

A self-assembly of an active tumor-targeted photothermal agent for enhanced anti-inflammatory cancer therapy

Abstract

A self-assembly of an active tumor-cell-targeted photothermal agent, functionalized with a cyclic Arg-Gly-Asp peptide and ibuprofen, for killing cancer cells and eliciting anti-inflammatory responses was developed. In vitro and in vivo experiments also demonstrated that the photothermal material exhibited low cytotoxicity, good biological compatibility and excellent tumor inhibitory effects.

Graphical abstract: A self-assembly of an active tumor-targeted photothermal agent for enhanced anti-inflammatory cancer therapy

Supplementary files

Article information

Article type
Communication
Submitted
29 Jul 2019
Accepted
11 Sep 2019
First published
19 Sep 2019

Nanoscale, 2019,11, 18021-18025

A self-assembly of an active tumor-targeted photothermal agent for enhanced anti-inflammatory cancer therapy

H. Wang, J. Chang, W. Pan, N. Li and B. Tang, Nanoscale, 2019, 11, 18021 DOI: 10.1039/C9NR06489C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements